NeuroMetrix, Inc.
NURO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -48.6% | -28.5% | 0% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 55.4% | 66.9% | 69.6% | 71.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -289.6% | -120.2% | -56.8% | -26.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -257.4% | -110.6% | -52.9% | -26.7% |
| EPS Diluted | -3.96 | -6.27 | -4.9 | -0.86 |
| % Growth | 36.8% | -28% | -469.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |